These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 33669512)
21. Pharmacokinetics and pharmacodynamics of the novel monobactam LYS228 in a neutropenic murine thigh model of infection. Growcott EJ; Cariaga TA; Morris L; Zang X; Lopez S; Ansaldi DA; Gold J; Gamboa L; Roth T; Simmons RL; Osborne CS J Antimicrob Chemother; 2019 Jan; 74(1):108-116. PubMed ID: 30325447 [TBL] [Abstract][Full Text] [Related]
22. Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints. Fratoni AJ; Nicolau DP; Kuti JL J Antimicrob Chemother; 2022 Mar; 77(4):1052-1060. PubMed ID: 35134195 [TBL] [Abstract][Full Text] [Related]
23. Huang Z; Bian X; Li Y; Hu J; Guo B; Yang X; Jin Y; Zheng S; Wang X; Gao C; Zhang J; Wu X Front Pharmacol; 2024; 15():1282480. PubMed ID: 38666023 [No Abstract] [Full Text] [Related]
24. Pharmacodynamics of Cefepime Combined with Tazobactam against Clinically Relevant Enterobacteriaceae in a Neutropenic Mouse Thigh Model. Melchers MJ; van Mil AC; Lagarde C; den Hartigh J; Mouton JW Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630197 [TBL] [Abstract][Full Text] [Related]
25. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models. Andes D; Craig WA Antimicrob Agents Chemother; 2006 Jan; 50(1):243-9. PubMed ID: 16377693 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection Model. Monogue ML; Tsuji M; Yamano Y; Echols R; Nicolau DP Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848004 [TBL] [Abstract][Full Text] [Related]
28. Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549 [TBL] [Abstract][Full Text] [Related]
29. In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae. Crandon JL; Nicolau DP Antimicrob Agents Chemother; 2015 May; 59(5):2688-94. PubMed ID: 25712356 [TBL] [Abstract][Full Text] [Related]
30. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus. Lepak AJ; Zhao M; Andes DR Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416551 [TBL] [Abstract][Full Text] [Related]
31. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Lepak AJ; Marchillo K; Craig WA; Andes DR Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404 [TBL] [Abstract][Full Text] [Related]
32. Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. Almarzoky Abuhussain SS; Kuti JL; Nicolau DP Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29914950 [TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model. Mavridou E; Melchers RJ; van Mil AC; Mangin E; Motyl MR; Mouton JW Antimicrob Agents Chemother; 2015 Feb; 59(2):790-5. PubMed ID: 25403667 [TBL] [Abstract][Full Text] [Related]
34. Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Zhang L; Zhou Z; Gu X; Huang S; Shen X; Ding H Front Vet Sci; 2020; 7():448. PubMed ID: 32851028 [TBL] [Abstract][Full Text] [Related]
35. Nakamura R; Ito-Horiyama T; Takemura M; Toba S; Matsumoto S; Ikehara T; Tsuji M; Sato T; Yamano Y Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262762 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an VanScoy BD; Tenero D; Turner S; Livermore DM; McCauley J; Conde H; Bhavnani SM; Rubino CM; Ambrose PG Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947475 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection Models. Bulik CC; Okusanya ÓO; Lakota EA; Forrest A; Bhavnani SM; Hoover JL; Andes DR; Ambrose PG Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872075 [TBL] [Abstract][Full Text] [Related]
38. Zhao M; Lepak AJ; Marchillo K; VanHecker J; Andes DR Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987156 [TBL] [Abstract][Full Text] [Related]
39. Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula. Medeiros AA; Crellin J Pediatr Infect Dis J; 1997 Mar; 16(3 Suppl):S49-55. PubMed ID: 9076836 [TBL] [Abstract][Full Text] [Related]
40. Activity of cefquinome against extended-spectrum β-lactamase-producing Klebsiella pneumoniae in neutropenic mouse thigh model. Shan Q; Wang J J Vet Pharmacol Ther; 2017 Aug; 40(4):392-397. PubMed ID: 27682189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]